Virtus Biotech ETF (BBP)

Funds & ETFs·etf
$104.76
+3.48% today
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
67/ 100
Score level
Above average
5 of 6 checks had data

Price trend is one of its highest-scoring factors, with business numbers score (revenue, margins, returns) is near the top of its range.

BBP scores higher than 98% of the 5,673 tickers we compare it with (Funds & ETFs).

As of 9 October 2026, Virtus Biotech ETF (BBP) scores 67 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

Insider trades: does not apply to this asset classTrendStrengthFinancialsInsidersInsider trades: does not apply to this asset classMarketMomentum67/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
0.66× 30-day average
52-week range
70.27 – 110.05
Market cap
—
Earnings date
—
Volume
8,894
Avg. volume (30d)
13,480
Open
101.84
Previous close
101.24
Day's range (regular session)
101.84 – 105.12

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
0.59
P/E (TTM)
—
EPS (TTM)
—

Score breakdown · six named factors

Price trend
90
Strength vs the market
58
Company finances
87
Insider trades
—
Market mood
50
Recent momentum
49

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about BBP right now

Virtus Biotech ETF (BBP) currently scores 67/100 on the Market Census six-factor composite, at the Above average score level. BBP is +3.48% on the day and +2.24% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for BBP leans good, with some weak spots. BBP's strongest factor is price trend at 90/100 — a very strong read on which way the price has been going. The weakest factor is Momentum at 49/100 — middling recent price moves. Low momentum + high trend often marks a base-building phase rather than a topping pattern.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See BBP in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent BBP news

Latest headlines that name Virtus Biotech ETF, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Funds & ETFs right now

Six funds & etfs tickers whose composite scores are closest to BBP’s 67, all within 1 point.

Sorted by closeness to BBP’s composite score within Funds & ETFs. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.